Micro Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BISOPROLOL FUMARATE USP, with a corresponding US DMF Number 37601.
Remarkably, this DMF maintains an Active status since its submission on November 11, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 16, 2022, and payment made on November 18, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II